Effect of adding exercise to a diet containing glucomannan

Metabolism: Clinical and Experimental

Volumn 56, Issue 8, 2007, Pages 1149-1158

  Kraemer, William J ^a   Vingren, Jakob L ^a   Silvestre, Ricardo ^a   Spiering, Barry A ^a   Hatfield, Disa L ^a   Ho, Jen Y ^a   Fragala, Maren S ^a   Maresh, Carl M ^a   Volek, Jeff S ^a  

^a UNIVERSITY OF CONNECTICUT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MANNAN;

ADULT; ARTICLE; BODY COMPOSITION; BODY FAT; BODY MASS; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DIET SUPPLEMENTATION; ENDURANCE; EXERCISE; FEMALE; HUMAN; MALE; OBESITY; PRIORITY JOURNAL; WAIST CIRCUMFERENCE; WEIGHT REDUCTION;

ADOLESCENT; ADULT; ANTHROPOMETRY; BLOOD GLUCOSE; BODY COMPOSITION; BODY MASS INDEX; DIET; ENZYME-LINKED IMMUNOSORBENT ASSAY; EXERCISE; EXERCISE TEST; FEMALE; HUMANS; INSULIN; LIPIDS; MALE; MANNANS; MIDDLE AGED; PHYSICAL ENDURANCE; PHYSICAL FITNESS; SEX CHARACTERISTICS; WEIGHT LIFTING; WEIGHT LOSS;

EID: 34347392074     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.metabol.2007.04.010     Document Type: Article

References (58)

1. Birketvedt G.S., Shimshi M., Erling T., and Florholmen J. Experiences with three different fiber supplements in weight reduction. Med Sci Monit 11 (2005) PI5-PI8
2. Howarth N.C., Saltzman E., and Roberts S.B. Dietary fiber and weight regulation. Nutr Rev 59 (2001) 129-139
3. Chen H.L., Sheu W.H., Tai T.S., Liaw Y.P., and Chen Y.C. Konjac supplement alleviated hypercholesterolemia and hyperglycemia in type 2 diabetic subjects-a randomized double-blind trial. J Am Coll Nutr 22 (2003) 36-42
4. Chandalia M., Garg A., Lutjohann D., von Bergmann K., Grundy S.M., and Brinkley L.J. Beneficial effects of high dietary fiber intake in patients with type 2 diabetes mellitus. N Engl J Med 342 (2000) 1392-1398
5. Vuksan V., Sievenpiper J.L., Owen R., Swilley J.A., Spadafora P., Jenkins D.J., et al. Beneficial effects of viscous dietary fiber from Konjac-mannan in subjects with the insulin resistance syndrome: results of a controlled metabolic trial. Diabetes Care 23 (2000) 9-14
6. Yoshida M., Vanstone C.A., Parsons W.D., Zawistowski J., and Jones P.J. Effect of plant sterols and glucomannan on lipids in individuals with and without type II diabetes. Eur J Clin Nutr 60 (2006) 529-537
7. Gallaher D.D., Gallaher C.M., Mahrt G.J., Carr T.P., Hollingshead C.H., Hesslink Jr. R., et al. A glucomannan and chitosan fiber supplement decreases plasma cholesterol and increases cholesterol excretion in overweight normocholesterolemic humans. J Am Coll Nutr 21 (2002) 428-433
8. Arvill A., and Bodin L. Effect of short-term ingestion of konjac glucomannan on serum cholesterol in healthy men. Am J Clin Nutr 61 (1995) 585-589
9. Martino F., Martino E., Morrone F., Carnevali E., Forcone R., and Niglio T. Effect of dietary supplementation with glucomannan on plasma total cholesterol and low density lipoprotein cholesterol in hypercholesterolemic children. Nutr Metab Cardiovasc Dis 15 (2005) 174-180
10. Garcia M.J., Charlez M., Del Pozo Carrascosa A., and Ghirardi P.E. Physiochemical comparison of the dietary fibers glucomannan, galactomannan, carboxymethylcellulose, pectin, and wheat bran. Curr Ther Res 43 (1988) 1010-1013
11. Livieri C., Novazi F., and Lorini R. The use of highly purified glucomannan-based fibers in childhood obesity. Pediatr Med Chir 14 (1992) 195-198
12. Vita P.M., Restelli A., Caspani P., and Klinger R. Chronic use of glucomannan in the dietary treatment of severe obesity. Minerva Med 83 (1992) 135-139
13. Cairella M., and Marchini G. Evaluation of the action of glucomannan on metabolic parameters and on the sensation of satiation in overweight and obese patients. Clin Ter 146 (1995) 269-274
14. Reffo G.C. Glucomannan in hypertensive outpatients: pilot clinical trial. Curr Ther Res 44 (1988) 22-27
15. Walsh D.E., Yaghoubian V., and Behforooz A. Effect of glucomannan on obese patients: a clinical study. Int J Obes 8 (1984) 289-293
16. Biancardi G., Palmiero L., and Ghirardi P.E. Glucomannan in the treatment of overweight patients with osteoarthrosis. Curr Ther Res 46 (1989) 908-912
17. Shima K., Tanaka A., Ikegami H., Tabata M., Sawazaki N., and Kumahara Y. Effect of dietary fiber, glucomannan, on absorption of sulfonylurea in man. Horm Metab Res 15 (1983) 1-3
18. Scalfi L., Coltorti A., D'Arrigo E., Carandente V., Mazzacano C., Di Palo M., et al. Effect of dietary fibre on postprandial thermogenesis. Int J Obes 11 Suppl 1 (1987) 95-99
19. Gallaher C.M., Munion J., Hesslink Jr. R., Wise J., and Gallaher D.D. Cholesterol reduction by glucomannan and chitosan is mediated by changes in cholesterol absorption and bile acid and fat excretion in rats. J Nutr 130 (2000) 2753-2759
20. Vuksan V., Jenkins D.J., Spadafora P., Sievenpiper J.L., Owen R., Vidgen E., et al. Konjac-mannan (glucomannan) improves glycemia and other associated risk factors for coronary heart disease in type 2 diabetes. A randomized controlled metabolic trial. Diabetes Care 22 (1999) 913-919
21. Venter C.S., Vorster H.H., and Van der Nest D.G. Comparison between physiological effects of konjac-glucomannan and propionate in baboons fed "Western" diets. J Nutr 120 (1990) 1046-1053
22. Kraemer W.J., Keuning M., Ratamess N.A., Volek J.S., McCormick M., Bush J.A., et al. Resistance training combined with bench-step aerobics enhances women's health profile. Med Sci Sports Exerc 33 (2001) 259-269
23. Tokmakidis S.P., and Volaklis K.A. Training and detraining effects of a combined-strength and aerobic exercise program on blood lipids in patients with coronary artery disease. J Cardiopulm Rehabil 23 (2003) 193-200
24. Kraemer W.J., Vescovi J.D., Volek J.S., Nindl B.C., Newton R.U., Patton J.F., et al. Effects of concurrent resistance and aerobic training on load-bearing performance and the Army physical fitness test. Mil Med 169 (2004) 994-999
25. Kraemer W.J., Volek J.S., Clark K.L., Gordon S.E., Incledon T., Puhl S.M., et al. Physiological adaptations to a weight-loss dietary regimen and exercise programs in women. J Appl Physiol 83 (1997) 270-279
26. Kraemer W.J., Volek J.S., Clark K.L., Gordon S.E., Puhl S.M., Koziris L.P., et al. Influence of exercise training on physiological and performance changes with weight loss in men. Med Sci Sports Exerc 31 (1999) 1320-1329
27. Kraemer W.J., and Fry A.C. Strength testing: development and evaluation of methodology. In: Maud P.J., and Foster C. (Eds). Physiological assessment of human fitness (1995), Human Kinetics, Champaign (Ill) 115-138
28. Carr T.P., Andresen C.J., and Rudel L.L. Enzymatic determination of triglyceride, free cholesterol, and total cholesterol in tissue lipid extracts. Clin Biochem 26 (1993) 39-42
29. Allain C.C., Poon L.S., Chan C.S., Richmond W., and Fu P.C. Enzymatic determination of total serum cholesterol. Clin Chem 20 (1974) 470-475
30. 2+ precipitation procedure for quantitation of high-density-lipoprotein cholesterol. Clin Chem 28 (1982) 1379-1388
31. Friedewald W.T., Levy R.I., and Fredrickson D.S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18 (1972) 499-502
32. Matthews D.R., Hosker J.P., Rudenski A.S., Naylor B.A., Treacher D.F., and Turner R.C. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28 (1985) 412-419
33. Ascaso J.F., Romero P., Real J.T., Priego A., Valdecabres C., and Carmena R. Insulin resistance quantification by fasting insulin plasma values and HOMA index in a non-diabetic population. Med Clin (Barc) 117 (2001) 530-533
34. Pfeiffer C.M., Huff D.L., and Gunter E.W. Rapid and accurate HPLC assay for plasma total homocysteine and cysteine in a clinical laboratory setting. Clin Chem 45 (1999) 290-292
35. Izquierdo M., Hakkinen K., Ibanez J., Kraemer W.J., and Gorostiaga E.M. Effects of combined resistance and cardiovascular training on strength, power, muscle cross-sectional area, and endurance markers in middle-aged men. Eur J Appl Physiol 94 (2005) 70-75
36. Esmaillzadeh A., Mirmiran P., and Azizi F. Comparative evaluation of anthropometric measures to predict cardiovascular risk factors in Tehranian adult women. Public Health Nutr 9 (2006) 61-69
37. Seidell J.C., Perusse L., Despres J.P., and Bouchard C. Waist and hip circumferences have independent and opposite effects on cardiovascular disease risk factors: the Quebec Family Study. Am J Clin Nutr 74 (2001) 315-321
38. Volek J., Sharman M., Gomez A., Judelson D., Rubin M., Watson G., et al. Comparison of energy-restricted very low-carbohydrate and low-fat diets on weight loss and body composition in overweight men and women. Nutr Metab (Lond) 1 (2004) 13
39. Larsson B., Seidell J., Svardsudd K., Welin L., Tibblin G., Wilhelmsen L., et al. Obesity, adipose tissue distribution and health in men-the study of men born in 1913. Appetite 13 (1989) 37-44
40. Varady K.A., Houweling A.H., and Jones P.J. Effect of plant sterols and exercise training on cholesterol absorption and synthesis in previously sedentary hypercholesterolemic subjects. Transl Res 149 (2007) 22-30
41. The Lipid Research Clinics Coronary Primary Prevention Trial results. II. The relationship of reduction in incidence of coronary heart disease to cholesterol lowering. JAMA 251 (1984) 365-374
42. The Lipid Research Clinics Coronary Primary Prevention Trial results. I. Reduction in incidence of coronary heart disease. JAMA 251 (1984) 351-364
43. D'Agostino Sr. R.B., Grundy S., Sullivan L.M., and Wilson P. Validation of the Framingham coronary heart disease prediction scores: results of a multiple ethnic groups investigation. JAMA 286 (2001) 180-187
44. Koro C.E., Bowlin S.J., Stump T.E., Sprecher D.L., and Tierney W.M. The independent correlation between high-density lipoprotein cholesterol and subsequent major adverse coronary events. Am Heart J 151 (2006) 755.e1-755.e6
45. Boule N.G., Weisnagel S.J., Lakka T.A., Tremblay A., Bergman R.N., Rankinen T., et al. Effects of exercise training on glucose homeostasis: the HERITAGE Family Study. Diabetes Care 28 (2005) 108-114
46. O'Donovan G., Kearney E.M., Nevill A.M., Woolf-May K., and Bird S.R. The effects of 24 weeks of moderate- or high-intensity exercise on insulin resistance. Eur J Appl Physiol 95 (2005) 522-528
47. Houmard J.A., Tanner C.J., Slentz C.A., Duscha B.D., McCartney J.S., and Kraus W.E. Effect of the volume and intensity of exercise training on insulin sensitivity. J Appl Physiol 96 (2004) 101-106
48. Dela F., Larsen J.J., Mikines K.J., Ploug T., Petersen L.N., and Galbo H. Insulin-stimulated muscle glucose clearance in patients with NIDDM. Effects of one-legged physical training. Diabetes 44 (1995) 1010-1020
49. Mikines K.J. The influence of physical activity and inactivity on insulin action and secretion in man. Acta Physiol Scand Suppl 609 (1992) 1-43
50. Vukovich M.D., Arciero P.J., Kohrt W.M., Racette S.B., Hansen P.A., and Holloszy J.O. Changes in insulin action and GLUT-4 with 6 days of inactivity in endurance runners. J Appl Physiol 80 (1996) 240-244
51. Blum W.F., Englaro P., Hanitsch S., Juul A., Hertel N.T., Muller J., et al. Plasma leptin levels in healthy children and adolescents: dependence on body mass index, body fat mass, gender, pubertal stage, and testosterone. J Clin Endocrinol Metab 82 (1997) 2904-2910
52. Lee J.H., Reed D.R., and Price R.A. Leptin resistance is associated with extreme obesity and aggregates in families. Int J Obes Relat Metab Disord 25 (2001) 1471-1473
53. Volek J.S., Gomez A.L., Love D.M., Weyers A.M., Hesslink Jr. R., Wise J.A., et al. Effects of an 8-week weight-loss program on cardiovascular disease risk factors and regional body composition. Eur J Clin Nutr 56 (2002) 585-592
54. Fatouros I.G., Tournis S., Leontsini D., Jamurtas A.Z., Sxina M., Thomakos P., et al. Leptin and adiponectin responses in overweight inactive elderly following resistance training and detraining are intensity related. J Clin Endocrinol Metab 90 (2005) 5970-5977
55. Sheu W.H., Wu H.S., Wang C.W., Wan C.J., and Lee W.J. Elevated plasma homocysteine concentrations six months after gastroplasty in morbidly obese subjects. Intern Med 40 (2001) 584-588
56. Fleming R.M. The effect of high-, moderate-, and low-fat diets on weight loss and cardiovascular disease risk factors. Prev Cardiol 5 (2002) 110-118
57. Dierkes J., Bisse E., Nauck M., Orth M., Mayer H., Luley C., et al. The diagnostic value of serum homocysteine concentration as a risk factor for coronary artery disease. Clin Chem Lab Med 36 (1998) 453-457
58. Henning B.F., Tepel M., Riezler R., Gillessen A., and Doberauer C. Vitamin supplementation during weight reduction-favourable effect on homocysteine metabolism. Res Exp Med (Berl) 198 (1998) 37-42